Elita platform combines dog stem cells with health data to help predict, prevent, and treat disease before symptoms appear.
Elita has raised $681K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2025.
Elita's investors include LaunchVic, Startmate, Archangel Ventures, Side Stage Ventures, XA Network.
Elita is headquartered in Melbourne, Australia.
Elita platform combines dog stem cells with health data to help predict, prevent, and treat disease before symptoms appear.
Elita is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elita — Funding & Investors." VCBacked, January 17, 2025, https://www.vcbacked.co/company/elita. Accessed August 14, 2026.
VCBacked. (2025). Elita — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/elita
{{cite web |title=Elita — Funding & Investors |url=https://www.vcbacked.co/company/elita |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated